Skip to main content

Table 2 Inputs for the scenario testing the impact of increasing diagnosis and treatment of HCV

From: Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality

Inputs

2013 (Base)

2014

2016

2018 and after

SVR G1

70%

80%

95%

95%

SVR G2

70%

85%

95%

95%

SVR G3

70%

70%

80%

90%

SVR G4

48%

80%

95%

95%

Age

15 - 64

15 - 64

15 - 69

15 - 74

Eligibility

60%

60% - 80%

80%

95%

Treated

5430

8150 [F2]

10190 [F2]

11710 [F1]

Diagnosed

5600

8400

13430

13430

Age

15 - 64

15 - 69

15 - 74

15 - 74